AnalyzeDirect Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. February 2007;68(7):501-508.
Publication Date
February 2007
How Analyze was Used
“Mean cerebellar tracer uptake was then calculated by sampling the 60- to 90-minute image in Analyze AVW 6.1.”
Keywords
Aged
Alzheimer Disease/diagnosis/metabolism/psychology
Amyloid/metabolism
Benzothiazoles/diagnostic use/pharmacokinetics
Brain/metabolism
Carbon Radioisotopes/diagnostic use
Cognition
Face
Female
Fluorodeoxyglucose F18/diagnostic use
Glucose/metabolism
Humans
Language
Male
Mental Recall
Middle Aged
Neuropsychological Tests
Positron-Emission Tomography (PET)
Radiopharmaceuticals/diagnostic use
Recognition (Psychology)
Author Affiliation(s)
MRC Clinical Sciences Centre and Division of Neuroscience, Hammersmith Hospital, Imperial College London. (PE, AH, NP, YFT, GH, AK, MR, DJB)
Dementia Research Centre, UCL, Institute of Neurology, GE Healthcare, UK. (HAA, DC, NF, MR)
Hammersmith Imanet, GE Healthcare, UK. (RH, DJB)
ID# 1808
Tags: Aged, Alzheimer Disease/diagnosis/metabolism/psychology, Amyloid/metabolism, Benzothiazoles/diagnostic use/pharmacokinetics, Brain/metabolism, Carbon Radioisotopes/diagnostic use, Cognition, Face, Female, Fluorodeoxyglucose F18/diagnostic use, Glucose/metabolism, Humans, Language, Male, Mental Recall, Middle Aged, Neuropsychological Tests, Positron Emission Tomography (PET), Radiopharmaceuticals/diagnostic use, Recognition (Psychology)